Joint Formulary & PAD

GP

Guideline Profile : Juvenile Idiopathic Arthritis

Drugs

Below are listed all drugs that are used to treat Juvenile Idiopathic Arthritis.

Committee Recommendations (0)

  • No records returned.

Guideline Profile

Indication :
Juvenile Idiopathic Arthritis
Keywords :
JIA, NICE, NHS England, pain, arthritis, SERMOG, South East Region Medicines Optimisation Group, polyarticular, polyarticular-onset, polyarticular-course, extended oligoarticular JIA
Brand Names Include :
Ilaris, Enbrel, Benepali, Erelzi, Orencia, Humira, RoActemra, Amgevita, Hyrimoz, Idacio, Imraldi, Yuflyma, Erelzi, Tyenne, tofacitinib, adalimumab, abatacept, tocilizumab, etanercept, Xelijanz,
Important Information :

Responsible commissioner is NHS England until the patient moves into the care of the adult service, at this point the responsible commissioner will be the ICB.

Latest Additions Date From :
05 Mar 2025
Latest Additions Date To :
Supporting Documents :
1